CoChat

Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Heat shock protein 90 (Hsp90) is a molecular chaperone that plays an important role in tumour biology by promoting the stabilisation and activity of oncogenic ‘client’ proteins. Inhibition of Hsp90 by small-molecule drugs, acting via its ATP hydrolysis site, has shown promise as a molecularly targeted cancer therapy. Owing to the importance of Hop and other tetratricopeptide repeat (TPR)-containing cochaperones in regulating Hsp90 activity, the Hsp90-TPR domain interface is an alternative site for inhibitors, which could result in effects distinct from ATP site binders. The TPR binding site of Hsp90 cochaperones includes a shallow, positively charged groove that poses a significant challenge for druggability. Herein, we report the apo, solution-state structure of Hop TPR2A which enables this target for NMR-based screening approaches. We have designed prototype TPR ligands that mimic key native ‘carboxylate clamp’ interactions between Hsp90 and its TPR cochaperones and show that they block binding between Hop TPR2A and the Hsp90 C-terminal MEEVD peptide. We confirm direct TPR-binding of these ligands by mapping 1 H–15 N HSQC chemical shift perturbations to our new NMR structure. Our work provides a novel structure, a thorough assessment of druggability and robust screening approaches that may offer a potential route, albeit difficult, to address the chemically challenging nature of the Hop TPR2A target, with relevance to other TPR domain interactors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-71969-w

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 NMR structures of the Hop TPR2A domain rotated 90° around the x-axis. (a) Ensemble views of the final 20 NMR models. (b) Ribbon representation of the ensemble average. (c) Electrostatic potential of the solvent-accessible surface calculated with the adaptive Poisson-Boltzmann solver (APBS) PyMol plug-in. Surface is coloured from − 10 kT/e negative charge in red to + 10 kT/e positive charge in blue. The strongly positively charged groove of Hop TPR2A is clearly defined.
Figure 1 NMR structures of the Hop TPR2A domain rotated 90° around the x-axis. (a) Ensemble views of the final 20 NMR models. (b) Ribbon representation of the ensemble average. (c) Electrostatic potential of the solvent-accessible surface calculated with the adaptive Poisson-Boltzmann solver (APBS) PyMol plug-in. Surface is coloured from − 10 kT/e negative charge in red to + 10 kT/e positive charge in blue. The strongly positively charged groove of Hop TPR2A is clearly defined.CC BY · PubMed Central
Figure 2 (a) Chemical structure of hit compound 7, identified from the in silico screening of commercially available diacid-containing compounds, and close analogue compound 8 (b) Representative concentration–response curves for inhibition of the Hop TPR2A-Hsp90 MEEVD interaction by compounds 7 and 8 with IC50 values denoted in the key (c) In silico docked pose of 7 (coral) against Hop TPR2A (turquoise surface) using docking software Glide (PDB code: 1ELR). The Hsp90 peptide (grey) is overlaid for comparison. The carboxylate clamp and hydrophobic binding regions are indicated.
Figure 2 (a) Chemical structure of hit compound 7, identified from the in silico screening of commercially available diacid-containing compounds, and close analogue compound 8 (b) Representative concentration–response curves for inhibition of the Hop TPR2A-Hsp90 MEEVD interaction by compounds 7 and 8 with IC50 values denoted in the key (c) In silico docked pose of 7 (coral) against Hop TPR2A (turquoise surface) using docking software Glide (PDB code: 1ELR). The Hsp90 peptide (grey) is overlaid for comparison. The carboxylate clamp and hydrophobic binding regions are indicated.CC BY · PubMed Central
Figure 3 Confirmation of small diacid 4 binding to the Hop TPR2A domain as determined by NMR chemical shift perturbations (CSPs). (a) Section of Hop TPR2A 1H-15 N HSQC spectra with the titration of 3 at 0, 50, 100, 750, 1,500 and 7,000 μM shaded black, red, orange, yellow, green and blue respectively. (b) CSPs of selected residues plotted against the peptide concentration and fitted (see “Methods”) to obtain Kd values. Mean Kd ± S.D. for 10 fitted residues was 3.1 ± 0.1 mM. (c) Surface representation of Hop TPR2A coloured by the magnitude of backbone amide CSPs at each residue. The Hsp90 peptide (grey) is overlaid for comparison. CSPs (∆δ) below 0.012 ppm are shown in white and those above 0.072 ppm in orange. Between these cut-offs CSP values are shaded from white to orange. Selected residues are labelled.
Figure 3 Confirmation of small diacid 4 binding to the Hop TPR2A domain as determined by NMR chemical shift perturbations (CSPs). (a) Section of Hop TPR2A 1H-15 N HSQC spectra with the titration of 3 at 0, 50, 100, 750, 1,500 and 7,000 μM shaded black, red, orange, yellow, green and blue respectively. (b) CSPs of selected residues plotted against the peptide concentration and fitted (see “Methods”) to obtain Kd values. Mean Kd ± S.D. for 10 fitted residues was 3.1 ± 0.1 mM. (c) Surface representation of Hop TPR2A coloured by the magnitude of backbone amide CSPs at each residue. The Hsp90 peptide (grey) is overlaid for comparison. CSPs (∆δ) below 0.012 ppm are shown in white and those above 0.072 ppm in orange. Between these cut-offs CSP values are shaded from white to orange. Selected residues are labelled.CC BY · PubMed Central
Figure 4 Confirmation of tryptoline compound binding to the Hop TPR2A domain as determined by NMR chemical shift perturbations (CSPs). (a) Section of Hop TPR2A 1H–15N HSQC spectra with the titration of 11 at 0, 50, 100, 750, and 1,500 μM shaded black, orange, yellow, green and blue respectively. (b) CSPs at selected residues plotted against the peptide concentration and fitted (see “Methods”) to obtain Kd values. Mean Kd ± S.D. for 10 residues was 177 ± 13 μM. (c) Surface representation of Hop TPR2A coloured by the magnitude of backbone amide CSPs at each residue. The Hsp90 peptide (grey) is overlaid for comparison. CSPs (∆δ) below 0.0375 ppm are shown in white and those above 0.131 ppm in orange. Between these cut-offs CSP values are shaded from white to orange.
Figure 4 Confirmation of tryptoline compound binding to the Hop TPR2A domain as determined by NMR chemical shift perturbations (CSPs). (a) Section of Hop TPR2A 1H–15N HSQC spectra with the titration of 11 at 0, 50, 100, 750, and 1,500 μM shaded black, orange, yellow, green and blue respectively. (b) CSPs at selected residues plotted against the peptide concentration and fitted (see “Methods”) to obtain Kd values. Mean Kd ± S.D. for 10 residues was 177 ± 13 μM. (c) Surface representation of Hop TPR2A coloured by the magnitude of backbone amide CSPs at each residue. The Hsp90 peptide (grey) is overlaid for comparison. CSPs (∆δ) below 0.0375 ppm are shown in white and those above 0.131 ppm in orange. Between these cut-offs CSP values are shaded from white to orange.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 17

Metadata

Authors
Darby, J. F., Vidler, L. R., Simpson, P. J., Al-Lazikani, B., Matthews, S. J., Sharp, S. Y., Pearl, L. H., Hoelder, S., & Workman, P.
Affiliations
  • Institute of Cancer Research (GB)
  • Bruker (United Kingdom) (GB)
  • Imperial College London (GB)
Corresponding author
Workman, Paul
Venue
Scientific Reports
Published
2020-09-29
Volume
10
Issue
1
Pages
16000-16000
ISSN
2045-2322 (ISSN-L)
OpenAlex
W3090160046
Cited by
17
References
70
Citations by year
2026: 1 · 2025: 3 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 4
FWCI
0.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Funders
  • Wellcome Trust (087370/Z/08/Z)
  • Cancer Research UK (C309/A11369, C309/A11566)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
Keywords
HSP90, tetratricopeptide repeat domain, co-chaperones, druggability, NMR structure, chemical shift perturbation, cancer therapy, targeted therapy
MeSH terms
Protein Domains, Computer Simulation, Heat-Shock Proteins, Humans, Ligands, Models, Molecular, Protein Binding, Protein Conformation, Nuclear Magnetic Resonance, Biomolecular, Catalytic Domain, Small Molecule Libraries

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches. https://app.cochat.ai/papers/10.1038/s41598-020-71969-w
The paper
Darby, J. F., Vidler, L. R., Simpson, P. J., Al-Lazikani, B., Matthews, S. J., Sharp, S. Y., Pearl, L. H., Hoelder, S., & Workman, P. (2020). Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches. Scientific Reports. https://doi.org/10.1038/s41598-020-71969-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.